Otolaryngology Doctors in Glen Burnie, MD Accepting Medicare

9 Otolaryngology doctors found. Showing 1 - 9

Dr. Alice E Chang, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 203 Hospital Dr, Suite 200, Glen Burnie, MD 21061 Phone: 410-760-8840    Fax: 410-760-8847

Kristin S. Dabbieri, AGNP-C Otolaryngology Medicare: Medicare Enrolled Practice Location: 802 Landmark Dr Ste 120, Glen Burnie, MD 21061 Phone: 410-760-8840

Dr. Alec Beningfield, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 203 Hospital Dr, Suite 200, Glen Burnie, MD 21061 Phone: 410-760-8840

Ms. Neda Ahmadi, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 203 Hospital Dr, Suite 200, Glen Burnie, MD 21061 Phone: 410-760-8840    Fax: 410-760-8847

Dr. Dwight Michael Patterson, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 203 Hospital Dr, Suite 200, Glen Burnie, MD 21061 Phone: 410-760-8840    Fax: 410-760-8847

Dr. Thomas Dae Lee, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 203 Hospital Dr, Suite 200, Glen Burnie, MD 21061 Phone: 410-760-8840    Fax: 410-760-8847

Diana Lee Schrieber, CRNP Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 802 Landmark Dr Ste 119, Glen Burnie, MD 21061 Phone: 410-760-8484    Fax: 410-367-2464

Dr. Carolina Trevino Guajardo, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 802 Landmark Dr Ste 119, Glen Burnie, MD 21061 Phone: 410-760-8840

Dr. Marc D Hamburger, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 203 Hospital Dr, Suite 200, Glen Burnie, MD 21061 Phone: 410-760-8840    Fax: 410-760-8847

News Archive

Politics swirl around approaching House repeal vote

As the House proceeds toward its scheduled Wednesday vote to repeal the health law, Republicans hope to draw more Democratic votes this time around - even though they have not offered any clear alternatives. Although the measure will die in the Senate, the White House issued a veto threat.

FDA accepts MAP Pharmaceuticals' resubmission of NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that its New Drug Application (NDA) resubmission for LEVADEX orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and Drug Administration (FDA).

Study emphasizes the need for doctors to understand what patients undergoing surgery really want

What do patients really want? These are important questions that doctors at the University of Vermont have tried to answer.

Cynosure 2010 fourth quarter revenues increase 16% to $22.3 million

Cynosure, Inc. today announced financial results for the three months and year ended December 31, 2010.

Read more Medical News

› Verified 3 days ago